Flavopiridol and Cisplatin Combination May Be Effective Against Platinum-Resistant Ovarian Cancer
Filed in archive Drugs, Vaccines and Therapeutics on October 25, 2007
Mayo Clinic has reported positive preliminary results in the Phase 11 clinical trials of a new combination therapy using flavopiridol (an investigational anti-cancer agent that also boosts the effects of other therapeutics including cisplatin) with cisplatin (a platinum compound) for women with platinum-resistant ovarian or primary peritoneal (lining of the abdominal cavity) cancers.
Of the 18 patients, all of whom were receiving the therapy as a second-line treatment after disease progression, one patient experienced complete response (all signs of cancer gone) and five other patients experienced partial responses (tumor regression). The 33 percent overall response rate (6 of 18 patients) is about twice as high as seen using traditional chemotherapy regimens.
The researchers also offered the combination therapy to five patients with platinum-sensitive (original therapy resulted in no recurrence for greater than 12 months) ovarian cancer. Of these women, one experienced complete response and three others partial response.
The researchers are now planning on expanding the trial to verify the results. Read more from the Mayo Clinic report.
The researchers also offered the combination therapy to five patients with platinum-sensitive (original therapy resulted in no recurrence for greater than 12 months) ovarian cancer. Of these women, one experienced complete response and three others partial response.
Permalink: Flavopiridol and Cisplatin Combination May Be Effective Against Platinum-Resistant Ovarian Cancer
Tags: cancer ovarian+cancer ovary+cancer chemotherapy cisplatin flavopiridol biotech platinum+resistant
Vote for Flavopiridol and Cisplatin Combination May Be Effective Against Platinum-Resistant Ovarian Cancer:
|
Rating: 7.25 out of 4 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells

